Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors

NCT02740933 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02740933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02740933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2016
Completion date
January 31, 2021
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor